ResearcherUniversity of LiverpoolActive in the last 2 years

Chloe Timmins-Young

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-5663-9120; OpenAlex author ID A5158975096. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

Protocol for eVLP-mediated CRISPR-Cas9 and prime editing in pancreatic cancer cell lines. Co-author DOI 10.1016/j.xpro.2026.104904 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marco Cordani · 1 shared paper, 2026 · strength 0.33
- Paper Protocol for eVLP-mediated CRISPR-Cas9 and prime editing in pancreatic cancer cell lines. DOI 10.1016/j.xpro.2026.104904 ↗
Mark A. Glenn · 1 shared paper, 2026 · strength 0.33
- Paper Protocol for eVLP-mediated CRISPR-Cas9 and prime editing in pancreatic cancer cell lines. DOI 10.1016/j.xpro.2026.104904 ↗
Elisa Giovannetti · 1 shared paper, 2026 · strength 0.33
- Paper Protocol for eVLP-mediated CRISPR-Cas9 and prime editing in pancreatic cancer cell lines. DOI 10.1016/j.xpro.2026.104904 ↗
Eithne Costello · 1 shared paper, 2026 · strength 0.33
- Paper Protocol for eVLP-mediated CRISPR-Cas9 and prime editing in pancreatic cancer cell lines. DOI 10.1016/j.xpro.2026.104904 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.